How many FDA warning letters has ASPIRO received?

Argus HQ has not recorded an FDA warning letter for ASPIRO in our current dataset.

What FDA recalls has ASPIRO issued?

Argus HQ has not recorded an FDA recall tied to ASPIRO in our current dataset.

Is ASPIRO FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for ASPIRO. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

ASPIRO

Name: FDA Enforcement Actions Against ASPIRO
Creator: Argus HQ
License: https://argushq.ai/methodology

Industry: Pharmaceutical

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_approval · anda2026-07-08
ASPIRO — ANDA approval: CYANOCOBALAMIN (unspecified)

Frequently asked questions

How many FDA warning letters has ASPIRO received?: Argus HQ has not recorded an FDA warning letter for ASPIRO in our current dataset.
What FDA recalls has ASPIRO issued?: Argus HQ has not recorded an FDA recall tied to ASPIRO in our current dataset.
Is ASPIRO FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for ASPIRO. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.